Division of Gastroenterology and Hepatology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Liver Transpl. 2013 Jan;19(1):89-95. doi: 10.1002/lt.23553. Epub 2012 Dec 12.
Although lower Model for End-Stage Liver Disease (MELD) scores due to lower levels of serum creatinine in women might account for some of the gender disparity in liver transplantation (LT) rates, even within MELD scores, women undergo transplantation at lower rates than men. It is unclear what causes this disparity, but transplant candidate/donor liver size mismatch may be a factor. We analyzed Organ Procurement and Transplantation Network data for patients with end-stage liver disease on the waiting list. A pooled conditional logistic regression analysis was used to assess the association between gender and LT and to determine the degree to which this association was explained by lower MELD scores or liver size. In all, 28,866 patients and 424,001 person-months were included in the analysis. The median estimated liver volume (eLV) and the median estimated liver weight (eLW) were significantly lower for women versus men on the LT waiting list (P < 0.001). When we controlled for the region and the blood type, women were 25% less likely to undergo LT in a given month in comparison with men (P < 0.001). When the MELD score was included in the model, the odds ratio (OR) for gender increased to 0.84, and this suggested that 9 percentage points of the 25% gender disparity were due to the MELD score. When eLV was added to the model, there was an additional 3% increase in the OR for gender, and this suggested that transplant candidate/donor liver size mismatch was an underlying factor for the lower LT rates in women versus men (OR = 0.87, P < 0.001). In conclusion, lower LT rates among women on the waiting list can be explained in part by lower MELD scores, eLVs, and eLWs in comparison with men. However, at least half of the gender disparity still remains unexplained.
虽然女性由于血清肌酐水平较低导致模型终末期肝病评分(MELD)较低,可能导致肝移植(LT)率存在性别差异,但即使在 MELD 评分范围内,女性接受 LT 的比例也低于男性。目前尚不清楚导致这种差异的原因,但移植候选者/供体肝大小不匹配可能是一个因素。我们分析了等待名单上终末期肝病患者的器官获取与移植网络数据。采用汇总条件逻辑回归分析评估性别与 LT 之间的关联,并确定 MELD 评分或肝大小对这种关联的解释程度。共有 28866 名患者和 424001 人月纳入分析。LT 等待名单上的女性中位估计肝体积(eLV)和中位估计肝重量(eLW)明显低于男性(P < 0.001)。当我们控制区域和血型时,与男性相比,女性在给定月份接受 LT 的可能性低 25%(P < 0.001)。当模型中纳入 MELD 评分时,性别比值比(OR)增加到 0.84,这表明 25%性别差异的 9 个百分点归因于 MELD 评分。当将 eLV 添加到模型中时,性别 OR 增加了 3%,这表明移植候选者/供体肝大小不匹配是女性 LT 率低于男性的一个潜在因素(OR = 0.87,P < 0.001)。总之,与男性相比,等待名单上女性 LT 率较低可部分归因于 MELD 评分较低、eLV 和 eLW。然而,至少一半的性别差异仍然无法解释。